Importance of the regulation of nuclear receptor degradation - PubMed (original) (raw)
Review
doi: 10.2741/dennis.
Affiliations
- PMID: 11487464
- DOI: 10.2741/dennis
Review
Importance of the regulation of nuclear receptor degradation
A P Dennis et al. Front Biosci. 2001.
Abstract
Nuclear hormone receptors (NHRs) represent a superfamily of structurally related ligand-activated transcription factors, which regulate diverse biological activities like growth, development, and homeostasis. Recently, it has been demonstrated that certain members of the NHR superfamily are degraded through the ubiquitin-proteasome pathway in a ligand-dependent manner. Though the signal for the down-regulation via the ubiquitin-proteasome pathway is not yet known, phosphorylation at specific amino acid residues or coactivator binding to receptors could lead to their degradation by the 26S proteasome. Activation and degradation seems to be an engineered cyclic mechanism, which provides tight control over diverse cellular processes. The degradation process involves extensive loss of proteins and requires expenditure of cellular ATP. That seems to be inevitable for a more important aim, that is efficient and appropriate regulation of transcription. Down-regulation of receptors would lead to an attenuated transcriptional response because the number of receptor molecules available to activate transcription would decrease over time. One of the obvious reasons for down-regulating NHRs thus seems to be to prevent the cell from overstimulation by the hormones or other activating signals. Nuclear receptor turnover may also reset the transcriptional apparatus in preparation for a subsequent response. Since inhibition of the ubiquitin-proteasome degradation pathway disturbs the transcriptional activitity of some of the nuclear receptors such as estrogen (ER) and progesterone (PR) receptors, it is also possible that the degradation of NHRs may enable recycling of components of receptor-cofactor complexes and general transcriptional machinary. Understanding the mechanism of nuclear hormone receptor degradation and its relation to transcription may lead to novel insights of therapuetic intervention.
Similar articles
- Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription?
Nawaz Z, O'Malley BW. Nawaz Z, et al. Mol Endocrinol. 2004 Mar;18(3):493-9. doi: 10.1210/me.2003-0388. Epub 2003 Dec 12. Mol Endocrinol. 2004. PMID: 14673136 Review. - Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes.
Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C. Blanquart C, et al. J Biol Chem. 2002 Oct 4;277(40):37254-9. doi: 10.1074/jbc.M110598200. Epub 2002 Jul 12. J Biol Chem. 2002. PMID: 12118000 - Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators.
Yan F, Gao X, Lonard DM, Nawaz Z. Yan F, et al. Mol Endocrinol. 2003 Jul;17(7):1315-31. doi: 10.1210/me.2002-0209. Epub 2003 Mar 27. Mol Endocrinol. 2003. PMID: 12663742 - Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors.
Masuyama H, Hiramatsu Y. Masuyama H, et al. J Biol Chem. 2004 Mar 26;279(13):12020-6. doi: 10.1074/jbc.M312762200. Epub 2003 Dec 30. J Biol Chem. 2004. PMID: 14702340 - The ubiquitin-proteasome pathway is a new partner for the control of insulin signaling.
Rome S, Meugnier E, Vidal H. Rome S, et al. Curr Opin Clin Nutr Metab Care. 2004 May;7(3):249-54. doi: 10.1097/00075197-200405000-00002. Curr Opin Clin Nutr Metab Care. 2004. PMID: 15075914 Review.
Cited by
- Turning off estrogen receptor beta-mediated transcription requires estrogen-dependent receptor proteolysis.
Tateishi Y, Sonoo R, Sekiya Y, Sunahara N, Kawano M, Wayama M, Hirota R, Kawabe Y, Murayama A, Kato S, Kimura K, Yanagisawa J. Tateishi Y, et al. Mol Cell Biol. 2006 Nov;26(21):7966-76. doi: 10.1128/MCB.00713-06. Epub 2006 Aug 28. Mol Cell Biol. 2006. PMID: 16940184 Free PMC article. - A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response.
Duska LR, Filiaci VL, Walker JL, Holman LL, Hill EK, Moore RG, Ring KL, Pearl ML, Muller CY, Kushnir CL, Lankes HA, Samuelson MI, Carrick KS, Rajan A, Rodgers WH, Kohn EC, Piekarz R, Leslie KK. Duska LR, et al. Clin Cancer Res. 2021 May 15;27(10):2734-2741. doi: 10.1158/1078-0432.CCR-20-4618. Epub 2021 Mar 25. Clin Cancer Res. 2021. PMID: 33766814 Free PMC article. Clinical Trial. - Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis.
Genini D, Carbone GM, Catapano CV. Genini D, et al. PPAR Res. 2008;2008:195065. doi: 10.1155/2008/195065. PPAR Res. 2008. PMID: 18551186 Free PMC article. - Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.
Jetten AM. Jetten AM. Nucl Recept Signal. 2009;7:e003. doi: 10.1621/nrs.07003. Epub 2009 Apr 3. Nucl Recept Signal. 2009. PMID: 19381306 Free PMC article. Review. - Expression of the novel human gene, UBE2Q1, in breast tumors.
Seghatoleslam A, Nikseresht M, Shafiee SM, Monabati A, Namavari MM, Talei A, Safaei A, Owji AA. Seghatoleslam A, et al. Mol Biol Rep. 2012 May;39(5):5135-41. doi: 10.1007/s11033-011-1309-x. Epub 2011 Dec 14. Mol Biol Rep. 2012. PMID: 22167327
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials